Evidence map›Paper›PMID 39250146›Full record

ArticleJAMA internal medicine2024

Charting the Waters of Sickle Cell Disease With Target Trial Emulation.

A Parker Ruhl, Matthew M Hsieh, Elizabeth A Stuart

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in JAMA internal medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

A Parker RuhlLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Matthew M HsiehCellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Elizabeth A StuartDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Funding

Nonmyeloablative allogeneic PBSC in globin disordersZ01HL006007 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI TISDALE, JOHN · 2008 to 2008
$384k
Intramural NIH HHS Z01 HL006007Intramural NIH HHS Z99 HL999999
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39250146
PMCPMC12757781

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.